
    
      Eligibility criteria: diagnosis of autism, no co-morbid diagnosis of Fragile X syndrome,
      epilepsy or tuberous sclerosis, aged between 4-10y11m.

      Experimental hypothesis: children with an autism spectrum disorder (ASD) on a GFCF diet would
      show a significantly improved group developmental outcome in the medium- and long-term with
      regards to core autism and/or secondary symptoms.

      Main outcome measures: change in scores of dietary participants on one or more measures
      against predefined statistical thresholds as evidence of improvement, alongside changes to
      intra- and inter-group scores at study endpoint.

      Main outcome measures ascertained by: Autism Diagnostic Observation Schedule (ADOS), Gillam
      Autism Rating Scale (GARS), Vineland Adaptive Behaviour Scales (VABS), Attention Deficit
      Hyperactivity Disorder - IV (ADHD-IV) scales.
    
  